| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How To Avoid Spamming! |
|
Main Subject - How To Avoid Spamming!
Mainly look at who your ads are being sent to. 1. If they are being sent to complete strangers, new prospects t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hat you've not had dealings with before,
then your ad should not mention the program, but rather ask
them to r ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in quest the information from you.
Once you receive this request, take a note of the email address and first name ( lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. at least),
and store them in a file (preferably a Group Mailer).
You can then email these people back (because here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hey are now an optin lead)
and advise your website details, etc..... 2. If they are being sent to your previous d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ly spoken to clients, no problem. 3. If they are members of the same club or program as you, and cross promotion ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s permitted,
again no problem. IMPORTANT: It is imperative to avoid SPAMMING that you include a DISCLAIMER CLA easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi USE
at the foot of every email you send out.
(Safelist advertising has its own so no need for one there). The nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Disclaimer Clause should say something to the effect: DISCLAIMER: This email cannot be considered SPAM as you hav and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e previously
requested information from me. or DISCLAIMER: This e-mail is sent in compliance with strict anti- ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi buse and NO SPAM regulations.
Your address was collected as a result of either posting to a link, a free classif ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ied ad,
or you have sent me your business proposition by e-mail in the past.
Under Bill S1618 TITLE III, passe dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod by the 105th US Congress, this message
cannot be considered SPAM as long as there is a way to be removed, paragr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin aph(a) (c) of S. 1618. or DISCLAIMER: Please refer to www.spamlaws.com/federal/hr3113.html This message is sen tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen in compliance with
the pending new Email bill, Section 301. paragraph (a) (2) (c) of S.1618. It is also imperat t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ive to avoid SPAMMING that you include a REMOVAL CLAUSE at the foot
of every email you send out. (Again safelist ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust are not necessary to do this with). The Removal Clause should say something to the effect: REMOVAL INSTRUCTIONS y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products : If you no longer wish to receive emails from me,
please click "Reply" to this email, and type or copy and past . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
in the subject area - REMOVE ME FROM YOUR EMAIL LIST. You may like to categorize your Email list, to relate it elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip to your own lists.
I have several different lists, I always categorize the list. Check out that you don't SPAM tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Small Commercial Printing Press Increasing Security: How to Avoid an Unnecessary Loss of Money
|